Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin specific peptidase 17 like family member 18 (USP17L18)
- Target
- USP17L18
- Molecular classification
- Enzyme, Ubiquitin-specific protease, Deubiquitinating enzyme
01
Overview
USP17L18 is a predicted deubiquitinating enzyme, classified as a member of the ubiquitin-specific protease family, with potential cysteine-type protease activity responsible for removing ubiquitin from specific target proteins[4]. The gene lacks detailed experimental characterization, and its exact biological function, disease relevance, and interactions remain poorly defined. It is likely to be involved in cellular protein stability and apoptotic regulation, similar to other USP17-like proteins, but direct evidence in humans is currently unavailable. No drugs, disease associations, or specific safety considerations have been published for this target.
- Other names
- Ubiquitin carboxyl-terminal hydrolase 17-like protein 18USP17L18
02
Mechanism of action
None identified; no mechanism established for drugs targeting USP17L18 (only predicted deubiquitinase activity)
03
Biological functions
Predicted cysteine-type deubiquitinase activityPossible roles in regulation of apoptotic processesPossible regulation of protein stability
04
Disease associations
Unknown; no published evidence of direct disease involvement or roles in cancer, inflammation, neurodegeneration, or infection for USP17L18 specifically
05
Safety considerations
None established; safety concerns or therapeutic challenges have not been published
06
Interacting drugs
None currently identified; no drugs are listed in public databases or literature as interacting with USP17L18
07
Biomarkers
None identified for patient selection or efficacy monitoring associated with USP17L18
Beyond the preview
Go deeper on Ubiquitin specific peptidase 17 like family member 18 (USP17L18).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ubiquitin specific peptidase 17 like family member 18 (USP17L18).